Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA Read more
GSK announces settlement between ViiV Healthcare and Gilead Sciences resolving litigation relating to Biktarvy and ViiV’s dolutegravir patents and entry into a patent licence agreement Read more
Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients Read more
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis Read more
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China Read more
European Commission Approves LORVIQUA (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer Read more
CHMP recommends approval of Dupixent (dupilumab) for children aged 6 to 11 years with severe asthma with type 2 inflammation Read more